Breaking News Instant updates and real-time market news.

2021-03-04 07:35:53 VRCA Verrica Pharmaceuticals $15.18 / +0.97 (+6.83%) 07:35 03/04/21 03/04 07:35 03/04/21 07:35	Verrica says Torii exercises option to acquire license for VP-102 On March 2, Torii Pharmaceutical Co. exercised its option to acquire an exclusive license to develop and commercialize Verrica's product candidates for the treatment of molluscum contagiosum and common warts in Japan, including VP-102. The parties have 60 days from the option exercise date to finalize and execute a license agreement. Under the terms of the Option Agreement, the license agreement would provide for Torii to make an up-front payment of $11.5 million, up to an additional $58 million in aggregate payments contingent on achievement of specified development, regulatory, and sales milestones, and tiered transfer price payments for supply of product in the percentage range of the mid-30s to the mid-40s of net sales. Torii would be responsible for all development activities and costs in support of obtaining regulatory approval in Japan.	23 Jun
VRCA Verrica Pharmaceuticals $15.18 / +0.97 (+6.83%) 12/24/20 Cowen Verrica approval for molluscum likely in Q3 of 2021, says Cowen 12/24/20 H.C. Wainwright Verrica Pharmaceuticals price target raised to $21 from $18 at H.C. Wainwright 07/15/20 BofA Verrica Pharmaceuticals downgraded to Neutral from Buy at BofA 06/30/20 H.C. Wainwright Verrica Pharmaceuticals price target lowered to $18 from $24 at H.C. Wainwright

2021-03-04 07:35:53

VRCA

Verrica Pharmaceuticals

$15.18 / +0.97 (+6.83%)

07:35

03/04/21

03/04

07:35

03/04/21

07:35

Verrica says Torii exercises option to acquire license for VP-102

On March 2, Torii Pharmaceutical Co. exercised its option to acquire an exclusive license to develop and commercialize Verrica's product candidates for the treatment of molluscum contagiosum and common warts in Japan, including VP-102. The parties have 60 days from the option exercise date to finalize and execute a license agreement. Under the terms of the Option Agreement, the license agreement would provide for Torii to make an up-front payment of $11.5 million, up to an additional $58 million in aggregate payments contingent on achievement of specified development, regulatory, and sales milestones, and tiered transfer price payments for supply of product in the percentage range of the mid-30s to the mid-40s of net sales. Torii would be responsible for all development activities and costs in support of obtaining regulatory approval in Japan.

23
Jun

VRCA Verrica Pharmaceuticals

$15.18 / +0.97 (+6.83%)

12/24/20 Cowen: Verrica approval for molluscum likely in Q3 of 2021, says Cowen

12/24/20 H.C. Wainwright: Verrica Pharmaceuticals price target raised to $21 from $18 at H.C. Wainwright

07/15/20 BofA: Verrica Pharmaceuticals downgraded to Neutral from Buy at BofA

06/30/20 H.C. Wainwright: Verrica Pharmaceuticals price target lowered to $18 from $24 at H.C. Wainwright

TODAY'S FREE FLY STORIES

Recommendations	Publicis price target raised to EUR 63 from EUR 54 at Credit Suisse » 12:58 04/16/21 04/16 12:58 04/16/21 12:58 PUBGY Publicis $16.23 / +0.43 (+2.72%) Credit Suisse analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals PUBGY Publicis $16.23 / +0.43 (+2.72%) 12/03/20 Visa taps Publicis, Wieden+Kennedy for global creative work 11/02/20 Hershey announces formal agency review for company's U.S. media PUBGY Publicis $16.23 / +0.43 (+2.72%) 04/09/21 Morgan Stanley Publicis price target raised to EUR 50 from EUR 46 at Morgan Stanley 04/08/21 JPMorgan Publicis price target raised to EUR 58 from EUR 48.59 at JPMorgan 04/05/21 Goldman Sachs Publicis price target raised to EUR 63 from EUR 52 at Goldman Sachs 03/01/21 Deutsche Bank Publicis price target raised to EUR 53 from EUR 40 at Deutsche Bank PUBGY Publicis $16.23 / +0.43 (+2.72%) 12/03/20 Visa picks Wieden+Kennedy, Publics after dropping BBDO, AdAge says 11/03/20 Interpublic Group agency Mediahub wins NBA business, Ad Age says
Recommendations	ASML price target raised to EUR 630 from EUR 540 at Credit Suisse » 12:57 04/16/21 04/16 12:57 04/16/21 12:57 ASML ASML $644.33 / +2.53 (+0.39%) Credit Suisse analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals ASML ASML $644.33 / +2.53 (+0.39%) 03/03/21 ASML says SMIC purchase agreement disclosure not material event ASML ASML $644.33 / +2.53 (+0.39%) 07:15 Today Wells Fargo ASML price target raised to $750 from $610 at Wells Fargo 04/14/21 Deutsche Bank ASML price target raised to EUR 500 from EUR 425 at Deutsche Bank 04/14/21 Barclays ASML price target raised to EUR 620 from EUR 525 at Barclays 03/22/21 Cowen ASML upgraded to Outperform from Market Perform at Cowen ASML ASML $644.33 / +2.53 (+0.39%) 01/20/21 ASML sees Q1 net sales EUR 3.9B-EUR 4.1B, gross margin 50%-51% 01/20/21 ASML reports Q4 EPS EUR 3.23 vs. EUR 2.54 last quarter ASML ASML $644.33 / +2.53 (+0.39%) 11/13/20 TSMC places EUV equipment orders with ASML for 2021, DigiTimes reports
Recommendations	ASM International price target raised to EUR 315 from EUR 265 at Credit Suisse » 12:57 04/16/21 04/16 12:57 04/16/21 12:57 ASMIY ASM International $320.00 / -0.97 (-0.30%) Credit Suisse analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research Events ASMIY ASM International $320.00 / -0.97 (-0.30%) 04/14/21 Deutsche Bank ASM International price target raised to EUR 300 from EUR 250 at Deutsche Bank 04/14/21 Barclays ASM International price target raised to EUR 295 from EUR 250 at Barclays 03/30/21 Morgan Stanley ASM International price target raised to EUR 240 from EUR 154 at Morgan Stanley 03/02/21 Deutsche Bank ASM International price target raised to EUR 250 from EUR 210 at Deutsche Bank 04/21/21 ASM International - ASMIY
Recommendations	Yara price target raised to NOK 360 from NOK 350 at Credit Suisse » 12:56 04/16/21 04/16 12:56 04/16/21 12:56 YARIY Yara $26.35 / +0.685 (+2.67%) Credit Suisse analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research YARIY Yara $26.35 / +0.685 (+2.67%) 04/14/21 UBS Yara price target raised to NOK 465 from NOK 450 at UBS 04/13/21 Berenberg Yara downgraded to Hold from Buy at Berenberg 04/07/21 Nordea Yara downgraded to Sell from Hold at Nordea 03/30/21 Pareto Yara downgraded to Hold from Buy at Pareto
Recommendations	HelloFresh price target raised to EUR 95 from EUR 81 at Credit Suisse » 12:54 04/16/21 04/16 12:54 04/16/21 12:54 HLFFF HelloFresh $88.48 / +4.03 (+4.77%) Credit Suisse analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings HLFFF HelloFresh $88.48 / +4.03 (+4.77%) 03/30/21 Sodexo, HelloFresh partner to launch on-campus meal kit delivery service HLFFF HelloFresh $88.48 / +4.03 (+4.77%) 12:27 Today Deutsche Bank HelloFresh price target raised to EUR 105 from EUR 99 at Deutsche Bank 04/07/21 JPMorgan HelloFresh price target raised to EUR 60 from EUR 55 at JPMorgan 03/08/21 Exane BNP Paribas HelloFresh downgraded to Underperform from Neutral at Exane BNP Paribas 02/04/21 Deutsche Bank HelloFresh price target raised to EUR 99 from EUR 68 at Deutsche Bank HLFFF HelloFresh $88.48 / +4.03 (+4.77%) 04/15/21 HelloFresh raises FY21 guidance, sees Q1 revenue and AEBITDA above consensus

Recommendations	Entain price target lowered to 1,850 GBp from 1,852 GBp at JPMorgan » 12:53 04/16/21 04/16 12:53 04/16/21 12:53 GMVHF Entain $22.25 / +0.62 (+2.87%) JPMorgan analyst Daniel… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals On The Fly GMVHF Entain $22.25 / +0.62 (+2.87%) 03/31/21 Detroit Tigers enters sponsorship agreement with BetMGM 03/30/21 BetMGM, Audacy announce multi-year strategic partnership 02/02/21 Entain confirms offer made to acquire Tabcorp's Wagering and Media business 01/19/21 Entain responds to MGM announcement, looks forward to continuing JV success GMVHF Entain $22.25 / +0.62 (+2.87%) 12:25 Today Deutsche Bank Entain price target raised to 1,872 GBp from 1,647 GBp at Deutsche Bank 04/12/21 RBC Capital Entain price target raised to 1,835 GBp from 1,700 GBp at RBC Capital 03/30/21 Barclays Entain price target raised to 2,000 GBp from 1,600 GBp at Barclays 03/30/21 JPMorgan Entain upgraded to Overweight from Neutral at JPMorgan GMVHF Entain $22.25 / +0.62 (+2.87%) 01/03/21 MGM makes new offer to acquire gaming company Entain, WSJ reports GMVHF Entain $22.25 / +0.62 (+2.87%) 01/22/21 Bet On It: Virginia and Michigan welcome online sports betting 01/19/21 DraftKings slips as analyst says sell on 'overoptimistic' share estimates 01/08/21 Bet On It: New York warming up to online sports betting 12/04/20 Bet On It: Michigan clears path for online gambling
Hot Stocks	CoreCivic trading resumes 12:53 04/16/21 04/16 12:53 04/16/21 12:53 CXW CoreCivic $8.24 / +0.1 (+1.23%) ShowHide Related Items >><< Company News Earnings Periodicals On The Fly Events Options CXW CoreCivic $8.24 / +0.1 (+1.23%) 12:33 Today CoreCivic announces agreement in principle to settle shareholder litigation 12:18 Today CoreCivic trading halted, news pending 04/07/21 CoreCivic falls -17.3% 01/06/21 CoreCivic falls -6.2% CXW CoreCivic $8.24 / +0.1 (+1.23%) 11/04/20 CoreCivic does not see issuing guidance until it has more clarity 11/04/20 CoreCivic reports Q3 adjusted EPS 28c, one estimate 22c CXW CoreCivic $8.24 / +0.1 (+1.23%) 01/26/21 Biden to limit government's use of private prisons, Reuters reports CXW CoreCivic $8.24 / +0.1 (+1.23%) 01/26/21 Fly Intel: Wall Street's top stories for Tuesday 05/13/21 CoreCivic Inc. CXW CoreCivic $8.24 / +0.1 (+1.23%) 11/02/20 CoreCivic call volume above normal and directionally bullish
Recommendations	Deutsche Wohnen price target raised to EUR 51 from EUR 43 at JPMorgan » 12:53 04/16/21 04/16 12:53 04/16/21 12:53 DTCWY Deutsche Wohnen $26.74 / +0.785 (+3.03%) JPMorgan analyst Neil… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research DTCWY Deutsche Wohnen $26.74 / +0.785 (+3.03%) 06:55 Today Societe Generale Deutsche Wohnen upgraded to Buy from Hold at Societe Generale 03/15/21 HSBC Deutsche Wohnen upgraded to Hold from Reduce at HSBC 02/01/21 Barclays Deutsche Wohnen upgraded to Overweight from Underweight at Barclays 12/02/20 Morgan Stanley Deutsche Wohnen upgraded to Overweight from Equal Weight at Morgan Stanley
Recommendations	Deutsche Bank price target raised to EUR 10 from EUR 9.60 at JPMorgan » 12:52 04/16/21 04/16 12:52 04/16/21 12:52 DB Deutsche Bank $12.46 / +0.17 (+1.38%) JPMorgan analyst Kian… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options DB Deutsche Bank $12.46 / +0.17 (+1.38%) 03/29/21 Deutsche Bank board extends CEO Sewing's contract until April 2026 03/29/21 Deutsche Bank: Chief Risk Officer Stuart Lewis to retire at AGM 2022 03/29/21 Deutsche Bank: COO Frank Kuhnke to leave company 03/29/21 Deutsche Bank confirms Fabrizio Campelli as head of Investment Bank DB Deutsche Bank $12.46 / +0.17 (+1.38%) 02/23/21 JPMorgan Deutsche Bank price target raised to EUR 9.60 from EUR 9 at JPMorgan 02/22/21 Berenberg Deutsche Bank price target raised to EUR 7 from EUR 5 at Berenberg 02/22/21 Barclays Barclays upgrades Deutsche Bank to Equal Weight on SPAC opportunity 02/22/21 Barclays Deutsche Bank upgraded to Equal Weight from Underweight at Barclays DB Deutsche Bank $12.46 / +0.17 (+1.38%) 02/04/21 Deutsche Bank reports Q4 group profit EUR 189M vs. (EUR 1.5B) last year 10/28/20 Deutsche Bank reports Q3 profit of EUR 309M, profit before tax EUR 482M DB Deutsche Bank $12.46 / +0.17 (+1.38%) 03/31/21 Deutsche sold $4B of Archegos holdings in private deal, Bloomberg reports 03/29/21 Deutsche Bank names Fabrizio Campelli investment bank head, Bloomberg reports 03/29/21 Deutsche Bank's Archegos exposure 'a fraction' of others, Reuters reports 03/26/21 Deutsche Bank CEO to relinquish investment bank role, Bloomberg reports DB Deutsche Bank $12.46 / +0.17 (+1.38%) 03/29/21 Analysts upgrade ViacomCBS, GSX Techedu as selloff in shares continues 01/08/21 Fly Intel: Wall Street's top stories for Friday 11/07/20 Week in review: How Trump's policies moved stocks DB Deutsche Bank $12.46 / +0.17 (+1.38%) 03/18/21 Deutsche Bank call volume above normal and directionally bullish 03/11/21 Unusually active option classes on open March 11th 03/09/21 Deutsche Bank call volume above normal and directionally bullish 03/08/21 Deutsche Bank call volume above normal and directionally bullish
Recommendations	BT Group price target raised to 230 GBp from 175 GBp at JPMorgan » 12:52 04/16/21 04/16 12:52 04/16/21 12:52 BTGOF BT Group $2.05 / -0.01 (-0.49%) JPMorgan analyst Akhil… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research BTGOF BT Group $2.05 / -0.01 (-0.49%) 03/31/21 BofA BT Group upgraded to Buy from Neutral at BofA 03/23/21 UBS BT Group price target raised to 108 GBp from 102 GBp at UBS 03/05/21 Barclays BT Group price target lowered to 170 GBp from 180 GBp at Barclays 03/05/21 Credit Suisse BT Group price target raised to 200 GBp from 190 GBp at Credit Suisse

Options	$140k call sale in Gold Fields reloads trade opened on March expiration date » 12:50 04/16/21 04/16 12:50 04/16/21 12:50 GFI Gold Fields $10.00 / +0.105 (+1.06%) $140k call sale in Gold… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals GFI Gold Fields $10.00 / +0.105 (+1.06%) 01/21/21 Gold Fields appoints Chris Griffith as CEO designate, succeeding Nick Holland 11/30/20 Galiano Gold provides Miradani North exploration update GFI Gold Fields $10.00 / +0.105 (+1.06%) 02/11/21 Goldman Sachs Gold Fields initiated with a Neutral at Goldman Sachs 09/14/20 RBC Capital Gold Fields coverage transferred with a Sector Perform at RBC Capital 06/22/20 JPMorgan Gold Fields upgraded to Overweight from Neutral at JPMorgan 04/21/20 BofA Gold Fields upgraded to Buy from Neutral at BofA GFI Gold Fields $10.00 / +0.105 (+1.06%) 03/15/21 Gold Fields 'uncooked alert' issued by Betaville blog
Options	Altimeter Growth Corp call volume above normal and directionally bullish » 12:45 04/16/21 04/16 12:45 04/16/21 12:45 AGC Altimeter Growth $12.98 / -0.52 (-3.85%) Bullish option flow… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Periodicals On The Fly Options AGC Altimeter Growth $12.98 / -0.52 (-3.85%) 04/13/21 Grab/Altimeter Growth combo to have equity value of $39.6B on pro-forma basis 04/13/21 Grab Holdings to go public via partnership with Altimeter Growth 03/11/21 Altimeter Growth, Altimeter Growth 2 rally after WSJ report of Grab talks AGC Altimeter Growth $12.98 / -0.52 (-3.85%) 11:28 Today Grab weighs secondary Singapore listing after SPAC deal, Reuters says 04/09/21 Grab to announce deal with Altimeter Growth SPAC next week, Bloomberg says 04/09/21 Grab to announce deal with Altimeter Growth SPAC next week, Bloomberg says 04/07/21 Altimeter Growth rallies after FT says deal with Singapore's Grab is close AGC Altimeter Growth $12.98 / -0.52 (-3.85%) 04/13/21 Fly Intel: Wall Street's top stories for Tuesday 04/13/21 Fly Intel: Wall Street's top stories at midday 04/13/21 Fly Intel: Pre-market Movers 04/11/21 On the Fly: The Week in SPAC News AGC Altimeter Growth $12.98 / -0.52 (-3.85%) 04/13/21 Unusually active option classes on open April 13th 02/24/21 Thirteen new option listings on February 24th
Syndicate	Recursion Pharmaceuticals opens at $30, IPO priced at $18 per share 12:42 04/16/21 04/16 12:42 04/16/21 12:42 RXRX Recursion Pharmaceuticals $0.00 / + (+0.00%) ShowHide Related Items >><< Syndicate 16 Apr
General news	FX Action: USD-JPY » 12:40 04/16/21 04/16 12:40 04/16/21 12:40 $ECON Economic Data / + FX Action: USD-JPY… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><<
Hot Stocks	U.S. exceeds 200M COVID-19 vaccine doses administered » 12:36 04/16/21 04/16 12:36 04/16/21 12:36 SPX S&P 500 / + , SPY SPDR S&P 500 ETF Trust $416.72 / +0.9 (+0.22%) , PFE Pfizer $38.45 / +0.84 (+2.23%) , BNTX BioNTech $151.80 / +11.16 (+7.94%) , MRNA Moderna $171.20 / +11.38 (+7.12%) , JNJ Johnson & Johnson $161.69 / +1.19 (+0.74%) White House COVID-19 data… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options Technical Analysis SPX SPY PFE BNTX MRNA JNJ SPX S&P 500 / + 03/29/21 Suez Canal Authority announces refloating of Ever Given ship 03/22/21 Biden intends to nominate Lina Khan for FTC commissioner 03/08/21 ARK's Wood thinks bull market 'broadening out' to include value, strengthening 03/08/21 Tepper tells CNBC he's getting bullish on stocks with rates stabilizing SPY SPDR S&P 500 ETF Trust $416.72 / +0.9 (+0.22%) 03/29/21 Suez Canal Authority announces refloating of Ever Given ship 03/22/21 Biden intends to nominate Lina Khan for FTC commissioner 03/08/21 ARK's Wood thinks bull market 'broadening out' to include value, strengthening 03/08/21 Tepper tells CNBC he's getting bullish on stocks with rates stabilizing PFE Pfizer $38.45 / +0.84 (+2.23%) 10:55 Today Moderna cuts April vaccine shipment to Canada to 650,000 from 1.2M 06:10 Today Ideaya Biosciences announces data from ongoing darovasertib, binimetinib trial 04/13/21 Pfizer can deliver 10% more vaccine doses to U.S. by end of May, says CEO 04/13/21 White House says J&J pause will not significantly impact vaccination plan BNTX BioNTech $151.80 / +11.16 (+7.94%) 04/13/21 Pfizer can deliver 10% more vaccine doses to U.S. by end of May, says CEO 04/09/21 Pfizer, BioNTech seek expansion of vaccine EUA to include 12-15 year olds 04/01/21 Pfizer, BioNTech: Vaccine more than 91% effective after 6 months in study 03/31/21 BioNTech, Pfizer: 'Positive' results of COVID-19 vaccine study in adolescents MRNA Moderna $171.20 / +11.38 (+7.12%) 10:55 Today Moderna cuts April vaccine shipment to Canada to 650,000 from 1.2M 04/14/21 Moderna says COVID-19 vaccine seen 90% effective against all cases at six months 04/14/21 Moderna says 14 different mRNA vaccine candidates entered into trials to date 04/14/21 Moderna sees Phase 1 study of mRNA flu vaccine candidate to begin in 2021 JNJ Johnson & Johnson $161.69 / +1.19 (+0.74%) 04/15/21 Evelo Biosciences appoints Luca Scavo as CFO, Julie McHugh to board of directors 04/15/21 Merck to discontinue development of MRK-7110 in COVID-19 treatment 04/14/21 EMA says 'expediting' evaluation of Johnson & Johnson COVID-19 vaccine 04/13/21 J&J pauses vaccinations in all COVID-19 vaccine clinical trials SPX SPY PFE BNTX MRNA JNJ SPX S&P 500 / + 03/15/21 Morgan Stanley Morgan Stanley equity strategist downgrades small cap stocks 03/12/21 On The Fly: Weekly technical notes for S&P 500 01/07/21 Credit Suisse Credit Suisse raises 2021 S&P 500 target to 4,200, sees 12% upside 11/09/20 JPMorgan JPMorgan sees S&P 500 hitting 4,000 by early next year SPY SPDR S&P 500 ETF Trust $416.72 / +0.9 (+0.22%) 03/15/21 Morgan Stanley Morgan Stanley equity strategist downgrades small cap stocks 03/12/21 On The Fly: Weekly technical notes for S&P 500 01/07/21 Credit Suisse Credit Suisse raises 2021 S&P 500 target to 4,200, sees 12% upside 11/09/20 JPMorgan JPMorgan sees S&P 500 hitting 4,000 by early next year PFE Pfizer $38.45 / +0.84 (+2.23%) 04/13/21 Morgan Stanley Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers 04/13/21 JPMorgan Vaccine pause 'incremental negative' for J&J, says JPMorgan 04/09/21 Pfizer to host conference call 04/06/21 RBC Capital Pfizer transferred with a Sector Perform at RBC Capital BNTX BioNTech $151.80 / +11.16 (+7.94%) 02/23/21 B. Riley Securities B. Riley remains 'aggressive' buyer of Novavax after updated FDA guidance 02/01/21 SVB Leerink Moderna price target raised to $80 from $69 at SVB Leerink 01/29/21 Piper Sandler Moderna, Pfizer keep Covid vaccine competitive advantage, says Piper Sandler 01/14/21 Morgan Stanley 80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley MRNA Moderna $171.20 / +11.38 (+7.12%) 04/15/21 Piper Sandler Moderna price target raised to $234 from $208 at Piper Sandler 04/13/21 Morgan Stanley Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers 04/13/21 Piper Sandler Piper reiterates $208 target on Moderna after J&J Covid vaccine pause 04/07/21 Jefferies Catalent pact with Moderna removes potential overhang, says Jefferies JNJ Johnson & Johnson $161.69 / +1.19 (+0.74%) 04/14/21 Guggenheim Emergent BioSolutions price target lowered to $110 from $130 at Guggenheim 04/13/21 Goldman Sachs J&J vaccine had numerical blood clot imbalance in trial, says Goldman Sachs 04/13/21 Morgan Stanley Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers 04/13/21 JPMorgan Vaccine pause 'incremental negative' for J&J, says JPMorgan SPX PFE MRNA JNJ SPX S&P 500 / + 02/23/21 S&P 500 targets FY21 EPS 3.00 to $3.20, consensus PFE Pfizer $38.45 / +0.84 (+2.23%) 02/02/21 Pfizer raises FY21 adjusted EPS view to $3.10-$3.20, consensus $3.19 02/02/21 Pfizer raises FY21 adjusted EPS view to $3.10-$3.20, consensus $3.19 02/02/21 Pfizer reports Q4 adjusted EPS 42c, consensus 48c 02/01/21 Notable companies reporting before tomorrow's open MRNA Moderna $171.20 / +11.38 (+7.12%) 02/25/21 Moderna reports Q4 EPS (69c), consensus (35c) 02/24/21 Notable companies reporting before tomorrow's open 02/24/21 Notable companies reporting before tomorrow's open 10/29/20 Moderna reports Q3 EPS (59c), consensus (43c) JNJ Johnson & Johnson $161.69 / +1.19 (+0.74%) 01/26/21 Johnson & Johnson sees FY21 adjusted operational EPS $9.25-$9.45 01/26/21 Johnson & Johnson reports Q4 adjusted EPS $1.86, consensus $1.82 01/25/21 Notable companies reporting before tomorrow's open 01/25/21 Notable companies reporting before tomorrow's open 23 Jul 19 May SPX SPY PFE BNTX MRNA JNJ SPX S&P 500 / + 04/14/21 Top White House officials to discuss vaccine rollout with House, CNBC says 04/14/21 Schumer to proceed with early infrastructure bill next week, Reuters says 04/06/21 California seeks to fully reopen economy June 15, L.A. Times reports 04/06/21 Biden to say all U.S. adults should be vaccine-eligible by April 19, WSJ says SPY SPDR S&P 500 ETF Trust $416.72 / +0.9 (+0.22%) 04/14/21 Top White House officials to discuss vaccine rollout with House, CNBC says 04/14/21 Schumer to proceed with early infrastructure bill next week, Reuters says 04/06/21 California seeks to fully reopen economy June 15, L.A. Times reports 04/06/21 Biden to say all U.S. adults should be vaccine-eligible by April 19, WSJ says PFE Pfizer $38.45 / +0.84 (+2.23%) 09:33 Today J&J reached out to vaccine rivals to study blood clot risk, WSJ reports 04/15/21 Pfizer CEO tells CNBC third vaccine dose likely needed within 12 months 04/14/21 Top White House officials to discuss vaccine rollout with House, CNBC says 04/13/21 NY replacing Tuesday's J&J vaccine appointments with Pfizer, Axios reports BNTX BioNTech $151.80 / +11.16 (+7.94%) 04/14/21 Top White House officials to discuss vaccine rollout with House, CNBC says 04/12/21 Study shows Covid variant may evade protection from Pfizer vaccine, Reuters says 04/09/21 EU seeks contract for 1.8B COVID-19 doses with Pfizer, BioNTech, Reuters reports 04/06/21 Biden to say all U.S. adults should be vaccine-eligible by April 19, WSJ says MRNA Moderna $171.20 / +11.38 (+7.12%) 09:33 Today J&J reached out to vaccine rivals to study blood clot risk, WSJ reports 04/14/21 Top White House officials to discuss vaccine rollout with House, CNBC says 04/14/21 Moderna discussing COVID vaccine manufacturing with Nexus, Reuters reports 04/14/21 Moderna talking with Nexus to boost vaccine production, Reuters reports JNJ Johnson & Johnson $161.69 / +1.19 (+0.74%) 09:33 Today J&J reached out to vaccine rivals to study blood clot risk, WSJ reports 04/15/21 CDC advisers to tentatively reconvene next week on J&J vaccine, Bloomberg says 04/15/21 Surgeon Gawande tells CNBC J&J vaccine pause should be lifted for older groups 04/15/21 J&J vaccine pause will likely last another week, FT reports PFE BNTX MRNA JNJ PFE Pfizer $38.45 / +0.84 (+2.23%) 04/15/21 Fly Intel: Wall Street's top stories for Thursday 04/13/21 Johnson & Johnson under pressure as FDA calls for pause on COVID vaccine 04/10/21 Opening Day: Phone maker UTime soars in public debut 04/09/21 Fly Intel: Wall Street's top stories for Friday BNTX BioNTech $151.80 / +11.16 (+7.94%) 04/09/21 Fly Intel: Wall Street's top stories for Friday 04/05/21 Fly Intel: Wall Street's top stories for Monday 04/01/21 Fly Intel: Wall Street's top stories for Thursday 04/01/21 Fly Intel: Wall Street's top stories at midday MRNA Moderna $171.20 / +11.38 (+7.12%) 04/14/21 Fly Intel: Wall Street's top stories for Wednesday 04/14/21 Fly Intel: Wall Street's top stories at midday 04/13/21 Fly Intel: After-Hours Movers 04/13/21 Fly Intel: Wall Street's top stories for Tuesday JNJ Johnson & Johnson $161.69 / +1.19 (+0.74%) 12:01 Today Fly Intel: Wall Street's top stories at midday 04/13/21 Fly Intel: Wall Street's top stories for Tuesday 04/13/21 Fly Intel: Wall Street's top stories at midday 04/13/21 Johnson & Johnson under pressure as FDA calls for pause on COVID vaccine 05/24/21 Global Healthcare Virtual Conference 2021 04/20/21 Johnson & Johnson - JNJ 05/04/21 Pfizer - PFE 05/06/21 Moderna - MRNA 05/07/21 Moderna - MRNA 05/10/21 BioNTech - BNTX 12/29/21 PDUFA Date for Lorbrena (Lorlatinib) April 2021 04/22/21 Pfizer Inc 04/22/21 Johnson & Johnson 04/28/21 Moderna, Inc. SPX SPY PFE BNTX MRNA JNJ SPX S&P 500 / + 09:18 Today Overnight activity included 935 trades in SPX and 29 trades in VIX 04/15/21 Overnight activity included 951 trades in SPX and 28 trades in VIX 04/14/21 Overnight activity included 632 trades in SPX and 31 trades in VIX 04/13/21 Overnight activity included 960 trades in SPX and 47 trades in VIX SPY SPDR S&P 500 ETF Trust $416.72 / +0.9 (+0.22%) 11/09/20 Options markets on track for record option volume PFE Pfizer $38.45 / +0.84 (+2.23%) 10:25 Today Pfizer call volume above normal and directionally bullish 09:40 Today Unusually active option classes on open April 16th 04/15/21 Pfizer call volume above normal and directionally bullish 04/12/21 Unusually active option classes on open April 12th BNTX BioNTech $151.80 / +11.16 (+7.94%) 02/17/21 Largest borrow rate increases among liquid names 01/26/21 BioNTech SE put volume heavy and directionally bearish 01/19/21 Largest borrow rate increases among liquid names 11/23/20 Largest borrow rate increases among liquid names MRNA Moderna $171.20 / +11.38 (+7.12%) 11:05 Today Moderna call volume above normal and directionally bullish 04/14/21 Moderna call volume above normal and directionally bullish 04/13/21 Moderna call volume above normal and directionally bullish 03/17/21 Moderna call volume above normal and directionally bullish JNJ Johnson & Johnson $161.69 / +1.19 (+0.74%) 04/13/21 Unusually active option classes on open April 13th 04/01/21 Unusually active option classes on open April 1st 03/01/21 Unusually active option classes on open March 1st 01/26/21 Early notable gainers among liquid option names on January 26th SPX SPY SPX S&P 500 / + 04/09/21 On The Fly: Weekly technical notes for S&P 500 04/01/21 On The Fly: Weekly technical notes for S&P 500 03/26/21 On The Fly: Weekly technical notes for S&P 500 03/19/21 On The Fly: Weekly technical notes for S&P 500 SPY SPDR S&P 500 ETF Trust $416.72 / +0.9 (+0.22%) 08:21 Today SPDR S&P 500 ETF Trust: Pivot points 04/15/21 SPDR S&P 500 ETF Trust: Pivot points 04/14/21 SPDR S&P 500 ETF Trust: Pivot points 04/13/21 SPDR S&P 500 ETF Trust: Pivot points

Periodicals	CVC to postpone Toshiba buyout offer after company names new CEO, Nikkei says » 12:35 04/16/21 04/16 12:35 04/16/21 12:35 TOSYY Toshiba $21.75 / -1.02 (-4.48%) CVC Capital Partners… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals On The Fly TOSYY Toshiba $21.75 / -1.02 (-4.48%) 04/14/21 Toshiba CEO Nobuaki Kurumatani steps down amid shareholder pressure 04/09/21 Toshiba chairperson Osamu Nagayama comments on CVC Capital acquisition proposal 04/06/21 Toshiba confirms acquisition proposal from CVC Capital 03/02/21 Farallon Capital urges Toshiba shareholders to support Farallon EGM proposal TOSYY Toshiba $21.75 / -1.02 (-4.48%) 03/19/21 SMBC Nikko Toshiba upgraded to Outperform from Neutral at SMBC Nikko 02/19/21 Citi Toshiba resumed with a Neutral at Citi 04/22/20 UBS Toshiba downgraded to Neutral from Buy at UBS TOSYY Toshiba $21.75 / -1.02 (-4.48%) 04/14/21 Toshiba CEO Kurumatani suddenly resigns, cast doubt on CVC deal, FT reports 04/13/21 KKR, Brookfield Asset Management mulling bid for Toshiba, Bloomberg reports 04/13/21 KKR planning to outbid CVC for Toshiba with offer in excess of $20B, FT reports 04/06/21 CVC to propose taking Toshiba private at 30% premium, Nikkei says TOSYY Toshiba $21.75 / -1.02 (-4.48%) 04/06/21 Fly Intel: Wall Street's top stories for Tuesday
Hot Stocks	CoreCivic announces agreement in principle to settle shareholder litigation » 12:33 04/16/21 04/16 12:33 04/16/21 12:33 CXW CoreCivic $8.24 / +0.1 (+1.23%) CoreCivic announced that… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Earnings Periodicals On The Fly Events Options CXW CoreCivic $8.24 / +0.1 (+1.23%) 12:18 Today CoreCivic trading halted, news pending 04/07/21 CoreCivic falls -17.3% 01/06/21 CoreCivic falls -6.2% 12/23/20 CoreCivic sells 42 government leased properties for $106.5M CXW CoreCivic $8.24 / +0.1 (+1.23%) 11/04/20 CoreCivic does not see issuing guidance until it has more clarity 11/04/20 CoreCivic reports Q3 adjusted EPS 28c, one estimate 22c CXW CoreCivic $8.24 / +0.1 (+1.23%) 01/26/21 Biden to limit government's use of private prisons, Reuters reports CXW CoreCivic $8.24 / +0.1 (+1.23%) 01/26/21 Fly Intel: Wall Street's top stories for Tuesday 05/13/21 CoreCivic Inc. CXW CoreCivic $8.24 / +0.1 (+1.23%) 11/02/20 CoreCivic call volume above normal and directionally bullish
Hot Stocks	Akers Biosciences announces stockholder approval for MyMD merger » 12:32 04/16/21 04/16 12:32 04/16/21 12:32 AKER Akers Biosciences $2.56 / -0.14 (-5.19%) , MYMD MyMD Pharmaceuticals / + Akers Biosciences and… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News AKER AKER Akers Biosciences $2.56 / -0.14 (-5.19%) 04/13/21 Akers proposed merger partner MyMD Pharmaceuticals to begin Covid trial 03/22/21 Akers Biosciences to hold shareholders meeting on April 15 to vote on MyMD deal 02/23/21 Akers Biosciences and MyMD Pharmaceuticals announce data on MYMD-1 02/17/21 Akers Biosciences says it has not scheduled any conference calls
Hot Stocks	RealPage to be halted following after-hours session on April 21, Nasdaq says » 12:29 04/16/21 04/16 12:29 04/16/21 12:29 RP RealPage $88.52 / +0.685 (+0.78%) Nasdaq stated in a notice… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events RP RealPage $88.52 / +0.685 (+0.78%) 02/16/21 Paulson & Co. buys Exxon, exits Qiagen in Q4 01/04/21 RealPage acquires WhiteSky 12/21/20 RealPage to be acquired by Thoma Bravo for $88.75 per share in cash 11/05/20 RealPage names Brian Shelton as new CFO RP RealPage $88.52 / +0.685 (+0.78%) 02/04/21 William Blair RealPage downgraded to Market Perform from Outperform at William Blair 12/22/20 JMP Securities RealPage price target raised to $101 from $80 at JMP Securities 12/22/20 Baird RealPage downgraded to Neutral from Outperform at Baird 12/21/20 BMO Capital RealPage downgraded to Market Perform from Outperform at BMO Capital RP RealPage $88.52 / +0.685 (+0.78%) 02/10/21 RealPage reports Q4 adjusted EPS 50c, consensus 48c 11/05/20 RealPage sees FY20 EPS $1.90-$1.94, consensus $1.81 11/05/20 RealPage sees Q4 EPS 46c-50c, consensus 45c 11/05/20 RealPage reports Q3 EPS 52c, consensus 45c 20 May RP RealPage $88.52 / +0.685 (+0.78%) 12/21/20 Fly Intel: Wall Street's top stories for Monday 12/21/20 Fly Intel: Wall Street's top stories at midday 12/21/20 Fly Intel: Pre-market Movers 04/20/21 RealPage - RP
Recommendations	Wizz Air price target lowered to 5,600 GBp from 5,650 GBp at Deutsche Bank » 12:28 04/16/21 04/16 12:28 04/16/21 12:28 WZZZY Wizz Air $17.10 / + (+0.00%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research WZZZY Wizz Air $17.10 / + (+0.00%) 03/30/21 Berenberg Wizz Air price target raised to 5,500 GBp from 5,000 GBp at Berenberg 03/03/21 HSBC Wizz Air downgraded to Reduce from Hold at HSBC 02/25/21 Deutsche Bank Wizz Air price target raised to 5,650 GBp from 4,900 GBp at Deutsche Bank 02/10/21 Exane BNP Paribas Wizz Air downgraded to Underperform from Neutral at Exane BNP Paribas

Recommendations	Aurubis price target raised to EUR 67 from EUR 64 at Deutsche Bank » 12:28 04/16/21 04/16 12:28 04/16/21 12:28 AIAGY Aurubis $41.30 / +0.8 (+1.98%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research AIAGY Aurubis $41.30 / +0.8 (+1.98%) 03/24/21 Morgan Stanley Aurubis price target lowered to EUR 62 from EUR 64 at Morgan Stanley 02/08/21 Deutsche Bank Aurubis price target raised to EUR 64 from EUR 62 at Deutsche Bank 01/27/21 Morgan Stanley Aurubis price target raised to EUR 64 from EUR 60 at Morgan Stanley 01/15/21 Deutsche Bank Aurubis price target raised to EUR 62 from EUR 61 at Deutsche Bank
Recommendations	HelloFresh price target raised to EUR 105 from EUR 99 at Deutsche Bank » 12:27 04/16/21 04/16 12:27 04/16/21 12:27 HLFFF HelloFresh $88.48 / +4.03 (+4.77%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings HLFFF HelloFresh $88.48 / +4.03 (+4.77%) 03/30/21 Sodexo, HelloFresh partner to launch on-campus meal kit delivery service HLFFF HelloFresh $88.48 / +4.03 (+4.77%) 04/07/21 JPMorgan HelloFresh price target raised to EUR 60 from EUR 55 at JPMorgan 03/08/21 Exane BNP Paribas HelloFresh downgraded to Underperform from Neutral at Exane BNP Paribas 02/04/21 Deutsche Bank HelloFresh price target raised to EUR 99 from EUR 68 at Deutsche Bank 01/22/21 Credit Suisse HelloFresh price target raised to EUR 81 from EUR 65 at Credit Suisse HLFFF HelloFresh $88.48 / +4.03 (+4.77%) 04/15/21 HelloFresh raises FY21 guidance, sees Q1 revenue and AEBITDA above consensus
Recommendations	Thyssenkrupp price target raised to EUR 17 from EUR 16 at Deutsche Bank » 12:27 04/16/21 04/16 12:27 04/16/21 12:27 TKAMY Thyssenkrupp $13.53 / -0.125 (-0.92%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals On The Fly TKAMY Thyssenkrupp $13.53 / -0.125 (-0.92%) 02/17/21 Thyssenkrupp ends deal talks with Liberty Steel over Steel Europe unit 12/22/20 Johnson Matthey, Thyssenkrupp renew partnership for ammonia production 11/19/20 Thyssenkrupp sees need for further reduction of 11,000 jobs altogether 11/19/20 Thyssenkrupp reaches pact to restructure automotive plant construction business TKAMY Thyssenkrupp $13.53 / -0.125 (-0.92%) 03/24/21 Morgan Stanley Thyssenkrupp price target raised to EUR 9 from EUR 8.10 at Morgan Stanley 03/18/21 Morgan Stanley Thyssenkrupp downgraded to Underweight from Equal Weight at Morgan Stanley 02/16/21 AlphaValue Thyssenkrupp upgraded to Add from Sell at AlphaValue 02/11/21 Deutsche Bank Thyssenkrupp price target raised to EUR 16 from EUR 13 at Deutsche Bank TKAMY Thyssenkrupp $13.53 / -0.125 (-0.92%) 03/05/21 Thyssenkrupp CEO says steel unit needs to cut costs, Reuters says 11/12/20 Thyssenkrupp reviewing ways to keep Uhde unit, Reuters reports TKAMY Thyssenkrupp $13.53 / -0.125 (-0.92%) 02/17/21 Fly Intel: Wall Street's top stories for Wednesday
Recommendations	Voestalpine price target raised to EUR 35 from EUR 31 at Deutsche Bank » 12:26 04/16/21 04/16 12:26 04/16/21 12:26 VLPNY Voestalpine $8.86 / +0.44 (+5.23%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research VLPNY Voestalpine $8.86 / +0.44 (+5.23%) 04/15/21 JPMorgan Voestalpine price target raised to EUR 32 from EUR 26 at JPMorgan 03/24/21 Morgan Stanley Voestalpine price target raised to EUR 31 from EUR 28 at Morgan Stanley 03/22/21 Goldman Sachs Voestalpine initiated with a Neutral at Goldman Sachs 02/24/21 AlphaValue Voestalpine upgraded to Add from Reduce at AlphaValue
Recommendations	Salzgitter price target raised to EUR 25 from EUR 22 at Deutsche Bank » 12:26 04/16/21 04/16 12:26 04/16/21 12:26 SZGPY Salzgitter $3.38 / + (+0.00%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research SZGPY Salzgitter $3.38 / + (+0.00%) 04/15/21 JPMorgan Salzgitter upgraded to Overweight from Neutral at JPMorgan 03/24/21 Morgan Stanley Salzgitter upgraded to Equal Weight from Underweight at Morgan Stanley 03/17/21 Deutsche Bank Salzgitter price target raised to EUR 22 from EUR 20 at Deutsche Bank 02/23/21 Baader Helvea Salzgitter upgraded to Buy from Reduce at Baader Helvea

Events

Earnings calls, analyst events, roadshows and more

EYPT
Today at 13:00

EyePoint - EYPT Conference Calls
DAL ...
Today at 13:00

Aerospace & Defense Industry Meetings
Today at 13:00

Hardware Industry Meetings
Today at 14:00

Large Cap Biotechnology Industry Meetings
TGTX
Tomorrow at 00:00

73rd Annual Virtual Meeting of AAN Conferences

Virtual Meeting
Tomorrow at 00:00

Texas A&M Bitcoin Virtual Conference 2021 Conferences

Virtual Conference
HDB
Tomorrow at 07:30

HDFC Bank - HDB Conference Calls
2021-04-18 at 00:00

73rd Annual Virtual Meeting of AAN Conferences

Virtual Meeting
RTX
2021-04-18 at 10:30

Raytheon Technologies Corporation Firm Sponsored Meetings
NPCE
2021-04-19 at 00:00

NeuroPace - NPCE Syndicate Roadshows

Virtual Meeting

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	CHWY X CHWY Chewy Block Trade Managers: Morgan Stanley Priced at: $82.50 6.1M Shares EPRT X EPRT Essential Properties Realty Trust Spot Secondary Managers: Citi, BofA & Barclays Priced at: $23.50 7.15M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial GFL X GFL GFL Environmental Spot Secondary Managers: BMO Capital, RBC Capital & Scotiabank Priced at: $33.95 17.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	DISCA X DISCA Discovery Block Trade Managers: Credit Suisse Priced at: $38.40 19M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial DISCK X DISCK Discovery Inc. Block Trade Managers: Credit Suisse Priced at: $32.35 22M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial IQ X IQ iQIYI Block Trade Managers: Credit Suisse Priced at: $15.85 35M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ALKT X ALKT Alkami IPO Managers: Goldman Sachs, JPMorgan & Barclays, Citi, William Blair, JMP Securities, KeyBanc, Needham Priced at: $30.00 6M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	COIN X COIN Coinbase Direct Listing Managers: Direct Listing Priced at: $250 Reference Price 114.851M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AGL X AGL Agilon Health IPO Managers: JPMorgan, Goldman Sachs & BofA, Deutsche Bank, Wells Fargo, William Blair, Truist, Nomura Priced at: $23.00 46.6M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial APP X APP AppLovin IPO Managers: Morgan Stanley, JPMorgan, KKR, BofA & Citi, Credit Suisse, UBS, Oppenheimer, Stifel, Truist, William Blair, Truist, Luma, Guzman & Company, LionTree Advisors, The Raine Group, Blaylock Van, R. Seelaus Priced at: $80.00 25M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial EBET X EBET Esports Technologies IPO Managers: Boustead Priced at: $6.00 2.4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial KRT X KRT Karat Packaging IPO Managers: Stifel, William Blair & Truist, National Securities, DA Davidson Priced at: $16.00 3.95M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial TSP X TSP TuSimple IPO Managers: Morgan Stanley, Citi & JPMorgan, BofA, Cowen, Credit Suisse, Nomura, RBC Capital, Baird, Needham, Oppenheimer, Piper Sandler, Valuable Capital Priced at: $40.00 33.784M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial NRZ X NRZ New Residential Secondary Managers: Citi, Goldman Sachs, BofA, JPMorgan & RBC Capital Priced at: $10.10 45M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	AKYA X AKYA Akoya Biosciences IPO Managers: JPMorgan, Morgan Stanley, Piper Sandler & Canaccord Priced at: $20.00 6.58M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BMEA X BMEA Biomea Fusion IPO Managers: JPMorgan, Jefferies & Piper Sandler Priced at: $17.00 9M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RXRX X RXRX Recursion Pharmaceuticals IPO Managers: Goldman Sachs & JPMorgan, BofA, SVB Leerink, Allen & Co., KeyBanc Priced at: $18.00 24.24M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BALY X BALY Bally's Secondary Managers: Deutsche Bank, Goldman Sachs & Barclays Priced at: $55.00 11M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MAXN X MAXN Maxeon Solar Secondary Managers: Morgan Stanley & BofA Priced at: $18.00 6.94M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PHX X PHX PHX Minerals Spot Secondary Managers: Stifel, Northland, Seaport Global Priced at: $2.00 5.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SPNE X SPNE SeaSpine Spot Secondary Managers: Piper Sandler, Canaccord, Stifel & Truist, BTIG, Cantor Fitzgerald, Ladenburg Priced at: $19.50 4.5M Shares SYBX X SYBX Synlogic Spot Secondary Managers: SVB Leerink Priced at: $3.00 10M Shares
Fri	No deals

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

View All Syndicate Announcements »

Verrica says Torii exercises option to acquire license for VP-102

TODAY'S FREE FLY STORIES

Get Full Fly Access